{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T14:55:32Z","timestamp":1791039332877,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,10,12]],"date-time":"2007-10-12T00:00:00Z","timestamp":1192147200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2007,11,28]]},"DOI":"10.1007\/s10096-007-0405-2","type":"journal-article","created":{"date-parts":[[2007,10,11]],"date-time":"2007-10-11T07:15:12Z","timestamp":1192086912000},"page":"37-43","source":"Crossref","is-referenced-by-count":64,"title":["One in five mortality in non-menstrual toxic shock syndrome versus no mortality in menstrual cases in a balanced French series of 55 cases"],"prefix":"10.1007","volume":"27","author":[{"given":"E.","family":"Descloux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Perpoint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Ferry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Lina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Vandenesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Mohammedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Etienne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,10,12]]},"reference":[{"key":"405_CR1","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1056\/NEJM199808203390806","volume":"339","author":"FD Lowy","year":"1998","unstructured":"Lowy FD (1998) Staphylococcus aureus infections. N Engl J Med 339:520\u2013532","journal-title":"N Engl J Med"},{"key":"405_CR2","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0891-5520(05)70324-X","volume":"10","author":"DL Stevens","year":"1996","unstructured":"Stevens DL (1996) The toxic shock syndromes. Infect Dis Clin North Am 10:727\u2013746","journal-title":"Infect Dis Clin North Am"},{"key":"405_CR3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1146\/annurev.micro.55.1.77","volume":"55","author":"JK McCormick","year":"2001","unstructured":"McCormick JK, Yarwood JM, Schlievert PM (2001) Toxic shock syndrome and bacterial superantigens: an update. Annu Rev Microbiol 55:77\u2013104","journal-title":"Annu Rev Microbiol"},{"key":"405_CR4","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1128\/JCM.42.6.2875-2876.2004","volume":"42","author":"PM Schlievert","year":"2004","unstructured":"Schlievert PM, Tripp TJ, Peterson ML (2004) Reemergence of staphylococcal toxic shock syndrome in Minneapolis-St. Paul, Minnesota, during the 2000\u20132003 surveillance period. J Clin Microbiol 42:2875\u20132876","journal-title":"J Clin Microbiol"},{"key":"405_CR5","first-page":"13","volume":"53","author":"S Holtfreter","year":"2005","unstructured":"Holtfreter S, Br\u00f6ker BM (2005) Staphylococcal superantigens: do they play a role in sepsis? Arch Immunol Ther Exp (Warsz) 53:13\u201327","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"405_CR6","first-page":"229","volume":"29","author":"Centers for Disease Control and Prevention (CDC)","year":"1980","unstructured":"Centers for Disease Control and Prevention (CDC) (1980) Toxic-shock syndrome\u2014United States. Morbid Mortal Weekly Rep 29:229\u2013230","journal-title":"Morbid Mortal Weekly Rep"},{"key":"405_CR7","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1146\/annurev.mi.38.100184.001531","volume":"38","author":"PJ Chesney","year":"1984","unstructured":"Chesney PJ, Bergdoll MS, Davis JP, Vergeront JM (1984) The disease spectrum, epidemiology, and etiology of toxic-shock syndrome. Annu Rev Microbiol 38:315\u2013338","journal-title":"Annu Rev Microbiol"},{"key":"405_CR8","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3201\/eid0506.990611","volume":"5","author":"RA Hajjeh","year":"1999","unstructured":"Hajjeh RA, Reingold A, Weil A, Shutt K, Schuchat A, Perkins BA (1999) Toxic shock syndrome in the United States: surveillance update, 1979\u20131996. Emerg Infect Dis 5:807\u2013810","journal-title":"Emerg Infect Dis"},{"key":"405_CR9","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJM198012183032502","volume":"303","author":"KN Shands","year":"1980","unstructured":"Shands KN, Schmid GP, Dan BB, Blum D, Guidotti RJ, Hargrett NT, Anderson RL, Hill DL, Broome CV, Band JD, Fraser DW (1980) Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases. N Engl J Med 303:1436\u20131442","journal-title":"N Engl J Med"},{"key":"405_CR10","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/S0140-6736(78)92274-2","volume":"2","author":"J Todd","year":"1978","unstructured":"Todd J, Fishaut M, Kapral F, Welch T (1978) Toxic-shock syndrome associated with phage-group-I Staphylococci. Lancet 2:1116\u20131118","journal-title":"Lancet"},{"key":"405_CR11","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/clinids\/16.1.100","volume":"16","author":"KC Kain","year":"1993","unstructured":"Kain KC, Schulzer M, Chow AW (1993) Clinical spectrum of nonmenstrual toxic shock syndrome (TSS): comparison with menstrual TSS by multivariate discriminant analyses. Clin Infect Dis 16:100\u2013106","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"405_CR12","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1093\/clinids\/11.Supplement_1.S14","volume":"11","author":"CV Broome","year":"1989","unstructured":"Broome CV (1989) Epidemiology of toxic shock syndrome in the United States: overview. Rev Infect Dis 11(Suppl 1):S14\u201321","journal-title":"Rev Infect Dis"},{"key":"405_CR13","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1128\/IAI.70.2.631-641.2002","volume":"70","author":"S Jarraud","year":"2002","unstructured":"Jarraud S, Mougel C, Thioulouse J, Lina G, Meugnier H, Forey F, Nesme X, Etienne J, Vandenesch F (2002) Relationships between Staphylococcus aureus genetic background, virulence factors, agr groups (alleles), and human disease. Infect Immun 70:631\u2013641","journal-title":"Infect Immun"},{"key":"405_CR14","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1128\/JCM.29.10.2240-2244.1991","volume":"29","author":"K Murakami","year":"1991","unstructured":"Murakami K, Minamide W, Wada K, Nakamura E, Teraoka H, Watanabe S (1991) Identification of methicillin-resistant strains of staphylococci by polymerase chain reaction. J Clin Microbiol 29:2240\u20132244","journal-title":"J Clin Microbiol"},{"key":"405_CR15","doi-asserted-by":"crossref","first-page":"871","DOI":"10.7326\/0003-4819-96-6-871","volume":"96","author":"AL Reingold","year":"1982","unstructured":"Reingold AL, Hargrett NT, Dan BB, Shands KN, Strickland BY, Broome CV (1982) Nonmenstrual toxic shock syndrome: a review of 130 cases. Ann Intern Med 96:871\u2013874","journal-title":"Ann Intern Med"},{"key":"405_CR16","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1001\/jama.1982.03320350052030","volume":"247","author":"P Bartlett","year":"1982","unstructured":"Bartlett P, Reingold AL, Graham DR, Dan BB, Selinger DS, Tank GW, Wichterman KA (1982) Toxic shock syndrome associated with surgical wound infections. JAMA 247:1448\u20131450","journal-title":"JAMA"},{"key":"405_CR17","doi-asserted-by":"crossref","first-page":"937","DOI":"10.7326\/0003-4819-96-6-937","volume":"96","author":"PM Schlievert","year":"1982","unstructured":"Schlievert PM, Osterholm MT, Kelly JA, Nishimura RD (1982) Toxin and enzyme characterization of Staphylococcus aureus isolates from patients with and without toxic shock syndrome. Ann Intern Med 96:937\u2013940","journal-title":"Ann Intern Med"},{"key":"405_CR18","doi-asserted-by":"crossref","first-page":"10102","DOI":"10.1073\/pnas.152152499","volume":"99","author":"N Vojtov","year":"2002","unstructured":"Vojtov N, Ross HF, Novick RP (2002) Global repression of exotoxin synthesis by staphylococcal superantigens. Proc Natl Acad Sci USA 99:10102\u201310107","journal-title":"Proc Natl Acad Sci USA"},{"key":"405_CR19","first-page":"710","volume":"139","author":"MJ Bresler","year":"1983","unstructured":"Bresler MJ (1983) Toxic shock syndrome due to occult postoperative wound infection. West J Med 139:710\u2013713","journal-title":"West J Med"},{"key":"405_CR20","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1086\/505428","volume":"194","author":"M Batisson","year":"2006","unstructured":"Batisson M, Strazielle N, Hejmadi M, Thomas D, Ghersi-Egea JF, Etienne J, Vandenesch F, Lina G (2006) Toxic shock syndrome toxin-1 challenges the neuroprotective functions of the choroidal epithelium and induces neurotoxicity. J Infect Dis 194:341\u2013349","journal-title":"J Infect Dis"},{"key":"405_CR21","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1189\/jlb.0306232","volume":"80","author":"O Dauwalder","year":"2006","unstructured":"Dauwalder O, Thomas D, Ferry T, Debard AL, Badiou C, Vandenesch F, Etienne J, Lina G, Monneret G (2006) Comparative inflammatory properties of staphylococcal superantigenic enterotoxins SEA and SEG: implications for septic shock. J Leukoc Biol 80:753\u2013758","journal-title":"J Leukoc Biol"},{"key":"405_CR22","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0891-5520(05)70082-9","volume":"13","author":"S Sriskandan","year":"1999","unstructured":"Sriskandan S, Cohen J (1999) Gram-positive sepsis. Mechanisms and differences from gram-negative sepsis. Infect Dis Clin North Am 13:397\u2013412","journal-title":"Infect Dis Clin North Am"},{"key":"405_CR23","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJM198012183032501","volume":"303","author":"JP Davis","year":"1980","unstructured":"Davis JP, Chesney PJ, Wand PJ, LaVenture M (1980) Toxic-shock syndrome: epidemiologic features, recurrence, risk factors, and prevention. N Engl J Med 303:1429\u20131435","journal-title":"N Engl J Med"},{"key":"405_CR24","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1172\/JCI110152","volume":"67","author":"CG Gemmell","year":"1981","unstructured":"Gemmell CG, Peterson PK, Schmeling D, Kim Y, Mathews J, Wannamaker L, Quie PG (1981) Potentiation of opsonization and phagocytosis of Streptococcus pyogenes following growth in the presence of clindamycin. J Clin Invest 67:1249\u20131256","journal-title":"J Clin Invest"},{"key":"405_CR25","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1128\/AAC.31.2.213","volume":"31","author":"DL Stevens","year":"1987","unstructured":"Stevens DL, Maier KA, Mitten JE (1987) Effect of antibiotics on toxin production and viability of Clostridium perfringens. Antimicrob Agents Chemother 31:213\u2013218","journal-title":"Antimicrob Agents Chemother"},{"key":"405_CR26","unstructured":"Parsonnet J, Modern PA, Giacobbe K (1994) Effect of subinhibitory concentrations of antibiotics on production of toxic shock syndrome toxin-1 (TSST-1). Presented at the 32nd Annual Meeting of the Infectious Diseases Society of America, Orlando, Florida, October 1994, abstract no 29"},{"key":"405_CR27","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1128\/IAI.56.1.135-141.1988","volume":"56","author":"PF Bonventre","year":"1988","unstructured":"Bonventre PF, Thompson MR, Adinolfi LE, Gillis ZA, Parsonnet J (1988) Neutralization of toxic shock syndrome toxin-1 by monoclonal antibodies in vitro and in vivo. Infect Immun 56:135\u2013141","journal-title":"Infect Immun"},{"key":"405_CR28","unstructured":"Melish ME, Frogner KS, Hirata SA, Murata MS (1987) Human gamma globulin therapy in experimental toxic shock syndrome (TSS). In: Program and Abstracts of the American Society of Microbiology, abstract no B194"},{"key":"405_CR29","doi-asserted-by":"crossref","first-page":"847","DOI":"10.7326\/0003-4819-96-6-847","volume":"96","author":"PJ Chesney","year":"1982","unstructured":"Chesney PJ, Crass BA, Polyak MB, Wand PJ, Warner TF, Vergeront JM, Davis JP, Tofte RW, Chesney RW, Bergdoll MS (1982) Toxic shock syndrome: management and long-term sequelae. Ann Intern Med 96:847\u2013851","journal-title":"Ann Intern Med"},{"key":"405_CR30","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1086\/380909","volume":"189","author":"V Gauduchon","year":"2004","unstructured":"Gauduchon V, Cozon G, Vandenesch F, Genestier AL, Eyssade N, Peyrol S, Etienne J, Lina G (2004) Neutralization of Staphylococcus aureus Panton Valentine leukocidin by intravenous immunoglobulin in vitro. J Infect Dis 189:346\u2013353","journal-title":"J Infect Dis"},{"key":"405_CR31","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1086\/515199","volume":"28","author":"R Kaul","year":"1999","unstructured":"Kaul R, McGeer A, Norrby-Teglund A, Kotb M, Schwartz B, O\u2019Rourke K, Talbot J, Low DE (1999) Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome\u2014a comparative observational study. The Canadian Streptococcal Study Group. Clin Infect Dis 28:800\u2013807","journal-title":"Clin Infect Dis"},{"key":"405_CR32","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1086\/376630","volume":"37","author":"J Darenberg","year":"2003","unstructured":"Darenberg J, Ihendyane N, Sj\u00f6lin J, Aufwerber E, Haidl S, Follin P, Andersson J, Norrby-Teglund A; StreptIg Study Group (2003) Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial. Clin Infect Dis 37:333\u2013340","journal-title":"Clin Infect Dis"},{"key":"405_CR33","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/jmr.612","volume":"16","author":"E Hong-Geller","year":"2003","unstructured":"Hong-Geller E, Gupta G (2003) Therapeutic approaches to superantigen-based diseases: a review. J Mol Recognit 16:91\u2013101","journal-title":"J Mol Recognit"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-007-0405-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-007-0405-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-007-0405-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T05:09:59Z","timestamp":1587964199000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-007-0405-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10,12]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,11,28]]}},"alternative-id":["405"],"URL":"https:\/\/doi.org\/10.1007\/s10096-007-0405-2","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10,12]]}}}